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SUMMARY
Chronic kidney disease (CKD) represents a major health burden1. Its central feature of renal 
fibrosis is not well understood. By whole exome resequencing in a model disorder for renal 
fibrosis, nephronophthisis (NPHP), we identified mutations of Fanconi anemia-associated 
nuclease 1 (FAN1) as causing karyomegalic interstitial nephritis (KIN). Renal histology of KIN is 
indistinguishable from NPHP except for the presence of karyomegaly2. FAN1 has nuclease 
activity, acting in DNA interstrand crosslinking (ICL) repair within the Fanconi anemia pathway 
of DNA damage response (DDR)3–6. We demonstrate that cells from individuals with FAN1 
mutations exhibit sensitivity to the ICL agent mitomycin C. However, they do not exhibit 
chromosome breakage or cell cycle arrest after diepoxybutane treatment, unlike cells from patients 
with Fanconi anemia. We complement ICL sensitivity with wild type FAN1 but not mutant cDNA 
from individuals with KIN. Depletion of fan1 in zebrafish revealed increased DDR, apoptosis, and 
kidney cysts akin to NPHP. Our findings implicate susceptibility to environmental genotoxins and 
inadequate DNA repair as novel mechanisms of renal fibrosis and CKD.
Nephronophthisis (NPHP)-related ciliopathies are a heterogeneous group of recessive 
diseases that cause CKD by chronic fibrosis and cyst development in the kidney7. To 
identify additional causative genes for NPHP we performed homozygosity mapping8 and 
whole exome resequencing9 in two siblings (A1170) of Maori descent (Table 1). Renal 
histology was indistinguishable from NPHP except for enlarged nuclei as seen in 
karyomegalic interstitial nephritis (KIN)10 (Figure 1). KIN is a kidney disease with renal 
tubular degeneration of unknown origin. It was first described in 197411 and given this term 
by Mihatsch et al2. KIN causes CKD on the basis of renal histologic changes characteristic 
for NPHP2, which are tubular basement membrane degeneration, atrophic tubules, tubular 
microcysts, interstitial infiltrations, and pronounced fibrosis (Figure 1a)12. The only 
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distinguishing feature from NPHP in KIN is the presence of karyomegaly (Figure 1b–c), 
which can also be present in lung, liver, and brain13. Currently, 12 families with KIN have 
been described10,14, compatible with autosomal recessive inheritance.
By homozygosity mapping in family A1170 we obtained 7 candidate regions of 
homozygosity by descent (Supplementary Figure 1A). Whole exome resequencing yielded a 
homozygous nonsense mutation (Trp707*) in FAN1 (Fanconi anemia-associated nuclease 
1) in both affected siblings (Supplementary Figure 1B, Table 1). No additional homozygous 
truncating mutations were detected in any other gene within the mapped candidate regions 
of A1170 (Supplementary Figure 1A). We then obtained DNA samples from 5 published 
KIN families and 5 unpublished cases (Table 1). Clinical phenotypes have been published 
for families A438515, A439316, A117010, A443313, and A433314 (Supplementary Table 1). 
Upon Sanger sequencing of all FAN1 exons, we found 12 different mutations of FAN1 in 9 
of the 10 families with KIN (Supplementary Figure 1B, Table 1), detecting both mutated 
alleles in 9 families (Table 1). Eight of the 12 mutations truncated the conceptual reading 
frame (Table 1). Three missense mutations, Gln929Pro, Gly937Asp and Asp960Asn, 
concerned amino acid residues that are conserved throughout evolution and are positioned in 
the nuclease domain (VRR-NUC) of FAN16. All mutations were absent from 96 healthy 
controls. We thus identified recessive mutations of FAN1 as the cause of KIN, an NPHP-like 
fibrotic kidney disease.
FAN1 is considered an effector of the Fanconi anemia pathway, a DNA damage response 
signaling (DDR) pathway devoted to repair of DNA interstrand crosslink (ICL) damage17. 
Individuals with Fanconi anemia are characterized by developmental abnormalities, bone 
marrow failure, and predisposition to cancer18. However, no FAN1 mutations were detected 
in Fanconi anemia individuals of unassigned complementation groups (F.P.L. and A.S., 
unpublished data). FAN1 is recruited to sites of ICL damage by interacting with a 
monoubiquitinated FANCI-FANCD2 (ID) complex through its UBZ domain3–6. In vitro, 
FAN1 exhibits nuclease activity.
We tested FAN1 expression in fibroblasts and lymphoblastoid cell lines from individuals 
with KIN (Figure 2a). As predicted, no FAN1 protein was detected in the three individuals 
(A1170-22, A4385-22 and A4466-21) who had two truncating mutations of FAN1 (Figure 
2a and Supplementary Fig. 2). Conversely, the protein was detected in the cell line from 
individual A4486-23 with a missense mutation (Asp960Asn) in the nuclease domain of 
FAN1 (Figure 2a).
As depletion of FAN1 sensitizes human cell lines to ICL agents3–6, we then examined 
FAN1-mutant cells from individuals with KIN for genome instability upon treatment with 
mitomycin C (MMC) (Figure 2b and Supplementary Table 2). We observed chromatid 
breaks and radial chromosomes on metaphase spreads (Figure 2b), which is consistent with 
a role of FAN1 in genome maintenance and DDR. The levels of genome instability observed 
in KIN cell lines were not as high as in FA cell lines that lack FANCA gene function 
(RA3087 and RA3157), but were above background seen in wild type cells (Supplementary 
Table 2). Interestingly, the classic test for FA, diepoxybutane (DEB) breakage19, was 
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negative in all FAN1-mutant cell lines tested but positive in the control FANCA mutant cell 
lines (RA3087 and RA3157) (Supplementary Table 2).
Despite the differences in apparent chromosomal instability following MMC and DEB 
treatment, survival of FAN1-mutant patient cell lines was severely compromised after 
treatment with either ICL agent (Figure 2c–f). ICL sensitivity was observed in multiple 
patient cell lines (Figure 2c–f). In contrast, cell cycle arrest in late S/G2 phase, which is 
characteristic of Fanconi anemia cells, was seen in FAN1-mutant cells only after MMC and 
not after DEB treatment (Figure 2g). These observed differences between FANCA mutant 
and FAN1 mutant cells might be explained by differential engagement of FAN1 versus other 
Fanconi anemia pathway-directed nucleases in the repair of different DNA ICL lesions, or 
by a different processing of the same kind of lesion by these distinct nucleases. Unlike the 
Fanconi anemia pathway defect, the FAN1 deficiency clearly results in high ICL sensitivity 
in the survival assays but does not lead to the profound genomic instability seen in Fanconi 
anemia cells. These differences in cellular phenotypes of FAN1-negative and FANCA 
negative cell lines may explain the lack of apparent phenotypic similarities between FAN1-
negative individuals, who present with KIN, and FA individuals who have bone marrow 
failure and cancer predisposition. A differential phenotype is also consistent with our finding 
that FAN1 is not necessary for activation of the FA pathway, as judged by normal FANCD2 
ubiquitination in FAN1 negative cells (Supplementary Fig. 3).
To complement the FAN1 defect, we transduced fibroblasts of individual A1170-22 with 
FAN1 cDNA of, i) wild type, ii) mutations from patients with KIN, or iii) mutations known 
to inhibit the nuclease activity (Glu975AlaLys977Ala) or the interaction with FANCD2 
(Cys44AlaCys47Ala)6 (Figure 3a–b). No FAN1 protein was detected upon immunoblotting 
when expressing the two truncating mutations Trp707* and Arg679Thrfs*5 suggesting that 
they are unstable, while L925Profs*25 yielded a shortened protein product (Figure 3b). 
Whereas wild type FAN1 did complement the MMC sensitivity defect, neither of the cDNAs 
representing mutations in individuals with KIN rescued the defect with the exception of 
Cys871Arg, which partially complemented cell survival upon MMC exposure, suggesting 
that it represents a hypomorphic allele of FAN1 (Figure 3a). Interestingly, the FAN1 
mutation Cys44AlaCys47Ala that abolishes FANCD2-dependent localization of FAN1 to 
sites of DNA damage6 was fully capable of rescuing the MMC resistance defect, strongly 
suggesting that FAN1 activity is independent of the FA pathway in cell lines from 
individuals with KIN. The Glu975AlaLys977Ala mutant lacking nuclease activity could not 
complement the FAN1 defect.
It was previously shown in DT40 chicken cells that deletion of FAN1 caused an effect on 
ICL sensitivity that was additive to the effect seen upon deletion of the Fanconi anemia 
genes FANCC and FANCJ20. To test whether inhibition of the Fanconi anemia pathway in 
the FAN1-mutant cells leads to increased ICL sensitivity, we depleted FANCD2, SLX4, or 
the SLX4-associated nucleases XPF and MUS81 (Figure 3c–d, Supplementary Fig. 4). Their 
depletion gave rise to profound MMC sensitivity that was greater than in cells with FAN1 
deficiency alone, suggesting that FAN1 can work independently of the Fanconi Anemia 
pathway in repair of ICL damage.
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The mechanisms that produce the fibrotic and cystic kidney phenotypes observed in NPHP-
related ciliopathies are still mostly unknown7,21,22. Because most DDR pathways as well as 
NPHP-related ciliopathies phenotypes are conserved in zebrafish23–27, we evaluated 
whether FAN1 loss of function would cause both, disturbance of DDR signaling and NPHP-
RC-like phenotypes by morpholino (MO) oligonucleotide knockdown of fan1 in zebrafish 
embryos. Injection into 1–4 cell stage embryos of an MO (fan1D7) that targets the splice 
acceptor site of exon 7 (Supplementary Fig. 5A–C) caused the characteristic NPHP-like 
phenotype of shortened body axis (Fig. 4a–b), but also the DDR phenotypes of 
microcephaly, microphthalmia, and massive cell death throughout the embryo (Fig. 4c). Cell 
death was from apoptosis as demonstrated by activated caspase-3 (Fig. 4d and 
Supplementary Fig. 5D–E). DDR signaling was activated with increased signal of γH2AX 
upon immunofluorescence (Fig. 4e and Supplementary Fig. 5F–G). These finding are 
similar to the ones described upon knockdown of the Fanconi anemia gene fancd2 in 
zebrafish28,29. However, in addition our fan1D7 MO morphants exhibited phenotypes 
characteristic of NPHP-related ciliopathies27, including ventral body axis curvature and 
renal cysts, when apoptosis was suppressed through knockdown of p53 function (Fig. 4f–h). 
Specifically, zebrafish embryos injected with fan1D7 MO and p53 MO at 72 hpf displayed 
pronephric kidney cysts (19±3%) (Fig. 4f,h) and body curvature (not shown) (45±4%), 
whereas p53 MO alone did not cause pronephric cysts (Fig. 4g,h) and caused body axis 
curvature in a significantly smaller fraction of embryos (11±2%) (Fig. 4h). Thus, loss of 
fan1 function results in ciliopathy-related phenotypes, which are further revealed when p53 
function is inhibited. The masking of the renal cystic phenotype in the presence of p53 
function is most likely due to the fact that fan1 morphants exhibited embryonic deformity 
(Fig. 4b–c) and strongly elevated apoptosis (Fig. 4d and Supplementary Fig. 5D–E), which 
prevented the observation of kidney cysts that developed in later embryonic stages. Our data 
demonstrate that loss of fan1 function in zebrafish embryos leads to a dual set of 
phenotypes, one representing activation of DDR and apoptosis (microcephaly and 
microphthalmia), the other mimicking NPHP-like ciliopathy phenotypes that are revealed 
when p53-dependent apoptosis is suppressed. Interestingly, we found that, while knockdown 
of fancd2 in zebrafish led to increased γH2AX staining, it did not cause kidney cysts or 
other ciliopathy phenotypes seen in fan1 knockdown (data not shown).
The clinical phenotypes in mutation of FAN1 vs. FANCD2 differ significantly. The former 
causes KIN and histologic karyomegaly in liver and brain, whereas the latter causes Fanconi 
anemia. To evaluate whether these phenotypic differences can be partially attributed to 
differential tissue expression, we performed quantitative PCR of 48 different human tissue 
sources, showing significant differences of expression levels in 25 sources. Interestingly, 
FAN1 expression exceeds FANCD2 in parenchymatous organs including the kidney, liver, 
neuronal tissue and female reproductive organs (Fig. 5a), whereas FANCD2 expression 
levels far exceed FAN1 expression in 6 different lymphatic or bone marrow-derived sources 
as well as in skin and testis (Fig. 5b). This may partially explain why FAN1 mutations cause 
KIN and karyomegaly in parenchymatous organs in the absence of Fanconi anemia-like 
blood dyscrasias, whereas FANCD2 mutation causes Fanconi anemia, with pancytopenia, 
skin involvement and male infertility. Fan1 expression by western blotting was particularly 
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high in the kidney (Supplementary Fig. 6) suggesting that the kidney might depend on 
FAN1 for its normal function.
We recently identified two additional genes that play a role in DDR signaling as causing 
NPHP-related ciliopathies if mutated.30 These findings strongly suggest that DDR may play 
a significant role in the pathogenesis of CKD in NPHP-related ciliopathies.
We therefore hypothesized that a defect in DDR signaling may represent a broader 
pathogenic mechanism that applies also to other forms of CKD. We therefore evaluated 
renal tissue sections from a standard congenic rat model for progressive chronic renal 
failure, the fawn-hooded hypertensive (FHH) rat, which has well-defined physiological 
parameters. Ten animals were selected based on disease progression at 9–10 months of age 
as measured by proteinuria.31 To determine the load of DDR in kidneys of these animals, we 
applied the widely accepted criterion of increased nuclear γH2AX activation on 
immunohistochemistry as readout (Fig. 5c–e). After staining, whole slides (2–4 kidney 
sections per animal) were digitally scanned and 10 randomized cortical fields were analyzed 
per section for positive nuclei using a modified algorithm used and calibrated for diagnostic 
pathology. In total, between 2,000–3,000 cells were scored blindly per animal. A positive 
correlation (R2=0.64, p<0.0054) was found between disease progression and DDR in this 
assay (Fig. 5c).
Having established the quantitative correlation in a well-defined congenic model for kidney 
disease we examined genetically heterogeneous human patients. A small pilot study using 
renal transplant biopsies from individuals clinically well-characterized by a 
nephropathologist and nephrologist supports the correlation found in the rat model. We 
examined γH2AX immunostaining of individuals four months post kidney transplantation 
with a histology report without injury and no proteinuria (Fig. 5f), a specimen from a 
transplant kidney 16 yrs after transplantation with (pathology report of “chronic damage”) 
(Fig. 5g), and a transplant kidney 10 years post-transplantation (pathology report of “chronic 
tissue damage”) (Fig. 5h). These data support in human CKD the relationship seen in the 
FHH rat model between the extent of kidney damage and DNA damage (γH2AX). They 
suggest that DDR may partially drive renal damage in pediatric NPHP-RC and in CKD of 
adults.
We here identify recessive mutations of FAN1 as causing KIN, which causes CKD with 
fibrotic degeneration of the kidney. Thus, DDR, which plays a known role in cellular 
senescence32 might contribute to the ‘premature aging’ phenotype of renal fibrosis in 
NPHP-like diseases. A KIN-like phenotype has also been described in humans and animal 
models that were exposed to ochratoxin A15, busulfan or pyrrolizidine alkaloids11, all of 
which cause DNA ICL. Thus, FAN1 mutation represents the genetic equivalent of 
environmental genotoxic causes of KIN by the shared pathogenic mechanism of defective 
DNA ICL repair. In this context it is interesting to note that among the 12 individuals with 
KIN and FAN1 mutations, CKD ensued by a median age at 45 years (Supplementary Table 
1) and that 7 of the 12 KIN individuals carried two truncating mutations or missense 
mutations in the nuclease domain of FAN1, which most likely represent null alleles (Table 1, 
Fig. 3a). This raises the question, whether other individuals, who carry two hypomorphic 
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alleles rather than two null alleles, might develop end-stage kidney disease even later in life. 
Interestingly, a high percentage of adult individuals treated within chronic dialysis programs 
suffer from fibrotic nephropathy of unknown cause. We will therefore follow up on the 
hypothesis that a significant number of cases in this cohort might be caused by two 
hypomorphic alleles of FAN1. Furthermore, as we demonstrate here that recessive mutations 
of FAN1 convey susceptibility to MMC and DEB, FAN1 mutations may also sensitize to 
other DNA ICL causing environmental genotoxins such as ochratoxin A, which are 
abundant16. Because CKD always exhibits a histologic phenotype of chronic interstitial 
fibrosis similar to the one observed in KIN, it will be important to examine a potential role 
of ICL-causing genotoxins for the absolute and relative increase in end-stage kidney disease 
that has been observed over the last 20 years in developed countries1.
ONLINE METHODS
Research subjects
We obtained blood samples and pedigrees following informed consent from individuals with 
KIN. Approval for human subjects research was obtained from the University of Michigan 
Institutional Review Board and the other institutions involved. The diagnosis of NPHP-RC 
was based on published clinical criteria. The clinical features of many individuals with KIN 
have been published (see also Table 1).10,13–16,33
Homozygosity mapping
For genome-wide homozygosity mapping8 the ‘Human Mapping 250k StyI’ array and the 
‘Genome-wide Human SNP 6.0 Array’ from Affymetrix™ were utilized. Genomic DNA 
samples were hybridized, and scanned using the manufacturer’s standard protocol at the 
University of Michigan Core Facility (www.michiganmicroarray.com). Non-parametric 
LOD scores were calculated using a modified version of the program GENEHUNTER 
2.134,35 through stepwise use of a sliding window with sets of 110 SNPs using the program 
ALLEGRO.36 Genetic regions of homozygosity by descent (‘homozygosity peaks’) were 
plotted across the genome as candidate regions for recessive disease-causing genes (see Fig. 
1a), as described.27,37 Disease allele frequency was set at 0.0001, and Caucasian marker 
allele frequencies were used.
Whole exome sequencing
Exome enrichment was conducted following the manufacturer’s protocol for the 
‘NimbleGen™ SeqCap EZ Exome v2’ beads (Roche NimbleGen Inc.). The kit interrogates a 
total of approximately 30,000 genes (~330,000 CCDS exons). Massively parallel sequencing 
was performed as described in Bentley et al.38
Mutation calling
Following whole exome sequencing, mutation calling was performed using the CLC 
Genomics Workbench™ software. Minimum length fraction of a read to match the reference 
sequence was set to 90%. For SNP detection, the minimum quality score of the central base 
and the minimum average quality score of surrounding bases were kept at default (20 and 
15, respectively). Quality assessment was performed within a window of 11 bases. Only 
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reads which uniquely aligned to the reference genome were used for variant SNP or DIP 
(deletion/insertion polymorphism) calling. In patients with evidence of homozygosity by 
descent, the threshold for the number of reads (minor allele frequency) was set to >55%.
Filtering of variants from normal reference sequence (VRS)27
For deletions/insertions (DIPs) and single nucleotide polymorphisms (SNPs) we used the 
following a priori criteria to restrict the high number of VRS (average of 53,272 for DIPs 
and 315,372 for SNPs) as follows:
i. We retained exonic variants (missense, nonsense, indels) and obligatory splice site 
variants only.
ii. We included only VRSs that are not listed in the data base ‘SNP129’ of innocuous 
polymorphisms.
iii. We evaluated exonic changes only within genomic regions, in which homozygosity 
mapping showed linkage for both affected siblings (retained average 38 for DIPs 
and 169 for SNPs).
iv. Variants were analyzed using the program BLAT (http://genome.ucsc.edu/cgi-bin/
hgBlat?command=start) at the UCSC human genome Bioinformatics Browser 
(http://genome.ucsc.edu/) for the presence of paralogous genes, pseudogenes, 
misalignments at ends of sequence reads, and whether the variant is a known 
dbSNP132 with an allele frequency >1% in Caucasian populations. In families in 
whom mapping demonstrated homozygosity by descent, we retained only 
homozygous variants and scrutinized all of them in the sequence alignments within 
CLC Genomics Workbench™ software for the presence of mismatches, indicating 
potential false alignments or poor sequence quality.
v. Sanger sequencing was performed to confirm the remaining variants in original 
DNA samples and to test for intrafamilial segregation in a recessive mode.
vi. Finally, remaining variants were ranked by the criteria whether mutations were 
truncating the conceptual reading frame (nonsense, frameshift and obligatory splice 
variants) or by evolutionary conservation analysis of missense variants, and by 
using web-based programs predicting the impact of disease candidate variants on 
the encoded protein or whether they were known disease-causing mutations.
Segregation analysis by Sanger sequencing
We applied Sanger dideoxy-terminator sequencing for confirmation and segregation of 
potential disease-causing variants in the respective patients, their affected siblings and their 
parents. In patients in whom only one heterozygous mutation was detected by exome 
capture and massively parallel sequencing, all exons and flanking intronic sequences of the 
respective gene(s) were analyzed by Sanger sequencing. Polymerase chain reaction (PCR) 
was performed using a touchdown protocol described previously.39 Sequencing was 
performed using BigDye® Terminator v3.1 Cycle Sequencing Kit on an ABI 3730 XL 
sequencer (Applied Biosystem). Sequence traces were analyzed using Sequencher (version 
4.8) software (Gene Codes Corporation).
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Web-based variant analysis
Predictions on the possible impact of an amino acid substitution on the chemical change, 
evolutionary conservation, and protein function were obtained by using the following web-
based programs: PolyPhen (Polymorphism Phenotyping, http://genetics.bwh.harvard.edu/
pph/), PolyPhen2 (http://genetics.bwh.harvard.edu/pph2/), SIFT, (Sorting Intolerant from 
Tolerant, http://sift.jcvi.org/), and Mutation Taster (http://www.mutationtaster.org/). GERP 
calculation was performed using http://gvs.gs.washington.edu/SeattleSeqAnnotation/.
Cell culture
Human fibroblasts cells were grown in 3% oxygen in Dulbecco Modified Eagle medium 
(DMEM) supplemented with 15% (v/v) FBS, 100 units of penicillin per ml, 0.1 mg 
streptomycin per ml, and non-essential amino acids (all from Invitrogen). BJ cells are 
normal foreskin fibroblasts and were obtained from ATCC. Fibroblasts were immortalized 
using pWZLhTERT or/and pMSCVNeo HPV16E6E7. Lymphoblast cell lines (LCLs) were 
immortalized using EBV and were grown in RPMI supplemented as above except with 20% 
FBS.
DNA damage sensitivity assay
Cells were plated in a 6-well plate in triplicate at a density of 5×104 cells per well for 
primary fibroblasts and LCLs or 2.5×104 cells per well for transformed fibroblasts. 
Immediately after plating for LCLs, or 24 hours later for fibroblasts, MMC or DEB was 
added at a final concentration from 0 to 100 nM for MMC or 1–0.75 μg/ml for DEB. After 6 
to 8 days in culture, cell numbers were determined using a Z2 Coulter Counter (Beckman 
Coulter). The cell number after MMC or DEB treatment was normalized to the cell number 
in the untreated sample to arrive at the % survival.
RNAi
For siRNA experiments, A1170-22 E6E7/hTERT cells were transfected with a pool of three 
siRNAs using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s 
instruction with the final concentration of total siRNA at 25 nM. siRNA sequences are 
shown in Supplementary Table 3.
Mutagenesis
Mutagenesis of FAN1 was performed on a pDONR223 FAN16 using multisite mutagenesis 
kit (Agilent). Primer sequences are shown in Supplementary Table 3. Other FAN1 mutants 
were described in6.
Antibodies
FAN1 antibody (RC394) was raised in a rabbit using GST-FAN1aa1-90 as an antigen and 
affinity-purified against HIS-FAN1aa1-90. Commercial antibodies were as follows: HA 
(Covance, MMS-101R), XPF/ERCC4 (Bethyl Laboratory, A301-315A), MUS81 (Sigma, 
M1445), FANCD2 (Novus, NB100-182).
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Breakage analysis
Cells were treated with 0.01 or 0.1 μg Diepoxybutane (DEB) per mL of media for 72 h or 
with 50 nM MMC for 24 h, arrested with colcemid (0.167 microgram per mL of media) for 
2 hours, harvested, incubated for 10 min at 37°C in 0.075 M KCl, and fixed in freshly 
prepared methanol:glacial acidic acid (3:1 v/v). Cells were stored at 4°C and when needed 
dropped onto wet slides and air-dried at 40°C for 60 minutes before staining with Karyomax 
Giemsa (Invitrogen) Gurr Buffer for 3 minutes. After rinsing with fresh Gurr Buffer 
followed by distilled water, the slides were fully dried at 40°C for 60 minutes and scanned 
using the Metasystems Metafer application.
Cell cycle analysis
Cells were left untreated, were treated with 100 nM MMC and grown for 48 hours, or were 
treated with 0.1 μg of Diepoxybutane (DEB) per ml and grown for 72 hours. Collected cells 
were resuspended in 300 μl PBS. While vortexing, 700 μl of ice cold 100% (v/v) ethanol 
was added dropwise, and the suspension was stored at −20°C at least overnight. Thirty 
minutes before fluorescence-activated cell sorting (FACS), cells were spun down, 
resuspended in propidium iodine mix (1 ml PBS, 10 μl RNase (of stock solution of 20 mg/
ml), 10 ml propidium iodine (of stock solution of 1 mg/ml)) and analyzed using 
FACSCalibur (Becton Dickinson). Cell cycle analysis was performed using the FlowJo 
software (Tree Star, Inc).
fan1 zebrafish morpholino oligo-mediated knockdown
Morpholino oligonucleotides (MO) were obtained from Gene Tools, LLC (Philomath, OR). 
MO (fan1D7 at 0.1 mM, standard control at 0.2 mM, and p53 MO at 0.2 mM) were injected 
into zebrafish embryos at 1–4 cell stages. Embryos were then fixed at 27 hpf with 4% 
PFA/PBS +1% DMSO overnight, permeablized with acetone at −20°C for 7 minutes, and 
stained with antibody against phosphorylated zebrafish γH2AX (1:1,000, gift from 
Amatruda lab at UT Southwestern, or antibody against cleaved Caspase-3 (1:200, BD 
Biosciences). Alex568-anti rabbit IgG was used at 1:2,000 and 1:1,000, respectively. The IF 
procedure followed standard protocol. After washing off secondary antibody, embryos were 
mounted in Vector-Shield Mounting Media and imaged with a Leica SP5X confocal system. 
Z-stacks were processed to reduce noise and overlayed to show the representative images of 
IF staining for γH2AX and cleaved caspase. DAPI was used to stain nuclei. Sequence of 
fan1D7 MO sequences is shown in Supplementary Table 3.
Quantitative real-time PCR
cDNAs of 48 human tissues were purchased from OriGene (Tissue SCANTM Normal 
Tissue qPCR Arrays cat. # HMRT502). Quantitative real-time PCR was performed using the 
TaqMan Gene Expression Assay Kit (Applied Biosystems) according to the manufacturer’s 
instructions. Briefly, 1 μL of cDNA was mixed with 10 μL of 2X TaqMan Universal Master 
Mix and 1 μL of the 20X TaqMan Gene Expression Assay, and was brought to a total 
volume of 20 μL by using RNase-free water. Target amplification was performed in 96-well 
plates using the StepOnePlusTM Real-Time PCR System (Applied Biosystems). TaqMan 
probes for FAN1 (Hs00429686_m1), FANCD2 (Hs00276992_m1), and glyceraldhyde-3-
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phosphate dehydrogenase (GAPDH) (Hs02758991_g1) were purchased from Applied 
Biosystems. PCR thermal cycling conditions included an initial 10 minutes hold at 95°C to 
activate the AmpliTaq Gold DNA polymerase, followed by 40 cycles of denaturation (15 
seconds at 95°) and annealing/primer extension (15 seconds at 60°C). More than triplicate 
real-time RT-PCR analyses were executed for each sample and the obtained threshold cycle 
values were averaged. The relative RNA expression levels were calculated via a 
comparative threshold cycle (Ct) method using GAPDH as control: ΔCt=Ct(GAPDH)-
Ct(FAN1 or FANCD2). The gene expression fold change, normalized to the GAPDH and 
relative to the control sample (FAN1 expression in the kidney), was calculated as 2−ΔΔCt.
Immunocytochemistry in the Fawn-Hooded Hypertensive rat and humans with kidney 
disease
Kidney tissue coupes of Fawn-Hooded Hypertensive rats (n=10) 31,40 embedded in paraffin 
were deparafinized and treated with PO block for 15 minutes and incubated at 100 °C in 
Citrate/HCL buffer for 20 minutes. The coupes were stained with mouse anti-γH2AX 
(1:200) overnight at 4°C. Polyclonal rabbit anti-mouse HRP (Dako, P0260) (1:100) was 
incubated 30 minutes at RT. Finally, BrightVision Poly HRP-Anti Rabbit IgG 
(Immunologic, DPVR55HRP) was incubated for 1 hour RT. Nova RED substrate kit for 
Peroxidase (Vector, SK-4800) was used and counterstained with hematoxyline. Analysis 
was performed using the Aperio ImageScope software. Ten random tubular fields in the 
cortex (approximately 270 cells per field) were analyzed for positive stained nuclei using an 
in-house algorithm macro. GraphPad Prism 5.0 was used to calculate the R square and p-
value.
Statistical analysis
Student’s two-tailed nonpaired t-tests and normal distribution two-tailed z-tests were carried 
out using pooled standard error and s.d. values to determine the statistical significance of 
different cohorts.
Bioinformatics
Genetic location is according to the March 2006 Human Genome Browser data (http://
www.genome.ucsc.edu).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Renal histology in individuals with karyomegalic interstitial nephritis (KIN)
Renal histology of individuals with FAN1 mutation exhibits the characteristic triad of 
nephronophthisis (NPHP), with cystic dilation of renal tubules (asterisks), interstitial 
infiltrations (encircled with a dotted line in a), and widespread fibrosis (blue-grey coloring 
in Trichrome-Masson staining in b). Karyomegaly is observed (white arrow heads in b and 
c) in tubules that have lost epithelial cells at their circumference (black arrow heads in b and 
c). The tubular basement membrane is thickened (double arrows in c) as well as attenuated 
(black arrow in c). a and b are from individual A4393-21, c is from individual A4466-21. 
Scale bars denote 100 μm.
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Figure 2. Phenotypes of FAN1-mutant cells
(a) Western blot analysis with anti-FAN1 antibody raised against the N-terminal 90 amino 
acids of FAN1. Specificity of the antibody was confirmed by the abrogation of signal after 
transduction of BJ fibroblasts with shRNAs against FAN1 and in individuals with protein 
truncating mutations in FAN1 (see Table 1). (b) Examples of metaphases of the indicated 
cell lines after treatment with 50 nM mitomycin C (MMC). Arrows indicate radial 
chromosomes, arrowheads indicate chromatid breaks. (c–f) MMC and diepoxybutane (DEB) 
sensitivity of the indicated FAN1-mutant cell lines in comparison to FANCA mutant and 
wild type cell lines. Primary fibroblast (FIB) (c and d) or lymphoblastoid cell lines (LCL) (e 
and f) were treated in triplicate with increasing levels of indicated DNA ICL inducing agent. 
After 6 or 8 days, cell numbers were determined using a Coulter counter. Total cell numbers 
at each dose were divided by the number of cells in the initial untreated sample to arrive at 
percent survival. Error bars indicate standard deviations. (g) Cell cycle analysis of the 
indicated fibroblast cell lines after treatment with 100 nM MMC or 0.1 μg of DEB per ml of 
media. Untreated samples were analyzed in parallel.
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Figure 3. Complementation of FAN1-mutant cells with FAN1 cDNAs, and epistasis analysis with 
genes implicated in ICL resistance
(a) Complementation of MMC sensitivity in fibroblasts of KIN individual A1170-22. 
Fibroblasts stably transduced with empty vector (vector control), vector expressing wild 
type FAN1 cDNA, or FAN1 cDNA with mutations incorporated (see Table 1) were exposed 
to different levels of MMC ranging from 0–100 nM. After 8 days, the cell number was 
determined using a Coulter counter. Total cell numbers at each dose were divided by the 
number of cells in the initial untreated sample to arrive at percent survival. Error bars 
indicate s.d. (b) Immunoblot showing expression levels of FAN1 alleles in A1170-22 
fibroblasts used in the MMC sensitivity assay shown in panel a. Note that Trp707* and 
Arg679Thrfs*5 lack expression of FAN1 and Leu925Profs*25 results in a shortened 
product. (c) MMC sensitivity in A1170-22 fibroblasts transfected with the indicated 
siRNAs. (d) Immunoblot of expression levels of indicated proteins after siRNA-mediated 
depletion in the A1170-22 fibroblasts used in the experiment shown in panel c.
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Figure 4. Phenotype of fan1 loss of function in zebrafish
(a–c) Knockdown of fan1 in zebrafish causes developmental abnormalities. A fan1D7 
morpholino (MO) that targets the splice acceptor site of exon 7 (Supplementary Fig. 5) was 
injected into 1–4 cell stage embryos at the concentrations shown. Standard control MO 
(Ctrl) was injected at 0.2 mM. At 25 hpf (b–c), morphant embryos displayed shortened body 
axis, ventral body axis curvature, and massive cell death (dark grey tissue areas) throughout 
the embryo (see c), when compared to control MO (a). Scale bar in a–c is 750 μm for left 
panels and 150 μm for right panels.
(d–e) Knockdown of fan1 in zebrafish induces widespread apoptosis. Upon fan1 
knockdown, utilizing fan1D7 MO as in (a–c), widespread apoptosis was seen in the anterior 
body (d) and the tail (Supplementary Fig. 5) of 27 hpf zebrafish, as detected by an antibody 
against activated caspase-3 (CASP3) compared to negative control morpholino. Images are 
representative for 32 embryos evaluated for control and MO knockdown, respectively. (e) 
Knockdown of fan1 leads to increased staining with γH2AX antibody, indicating increased 
DDR. In knockdown embryos, 24 out of 27 embryos had elevated Caspase-3 staining, and 
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27 of 32 embryos stained with γH2AX had elevated expression of γH2AX. Scale bar is 250 
μm. (See also Supplementary Fig. 5.)
(f–h) Knockdown of fan1 on the background of p53 morphants reveals pronephric cysts. (f) 
p53 knockdown alone does not cause pronephric cysts in 72 hpf embryos exhibiting normal 
pronephric tubules (arrows). (g) However, 72 hpf zebrafish embryos co-injected with 
fan1D7 MO (0.1 mM) and p53 MO (0.2 mM) display pronephric kidney cysts (19±3%) 
(asterisks in g) and results in body axis curvature (not shown) (45±4%). (g–h) it causes body 
axis curvature in a significantly smaller fraction (11±2%; not shown). Scale bar is 50 μm.
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Figure 5. Differential expression levels of FANCD2 vs. FAN1 in human tissue sources and 
increased DNA damage response in chronic kidney disease
Expression levels measured by quantitative real-time PCR were normalized against GAPDH 
expression. Error bars show SEM of triplicates.
(a–b) Expression levels of FANCD2 vs. FAN1 in 25 different human tissue sources (of 48 
total with differential expression). (a) FAN1 expression exceeded FANCD2 in 
parenchymatous organs including kidney, liver, neuronal tissue and female reproductive 
organs, whereas (b) FANCD2 expression exceeds FAN1 expression in lymphatic or bone 
marrow-derived sources, skin and testis.
(c–h) DNA damage response is pronounced in chronic kidney disease.
(c) Quantified percent of γ-H2AX staining of fawn-hooded hypertensive rat kidneys 
(between 2,000–3,000 cells scored per animal) with progressive kidney injury31 correlates 
with proteinuria (p<0.0054).
(d) Example of γ-H2AX immunostaining in normal rat kidney.
(e) Example of chronically damaged kidney in the fawn hooded hypertensive rat.
(f–h) γ-H2AX staining of human kidney transplant biopsies: Transplant kidney, 4 months 
post-transplantation, no evidence for injury (f); transplant kidney, 16 yrs after 
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transplantation, chronic damage (g); transplant kidney with chronic tissue damage, 10 years 
post-transplantation (h). Scale bars in d–h are 100 μm.
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